Researchers from Aarhus University—in a major international collaboration—have developed a groundbreaking method that can ...

The incidence and prevalence of CTD-ILD in the US is most common among women and older individuals, affecting approximately 116,000 to 118,000 adults.

A mum is fundraising for treatment for her son's rare illness in Italy. Now aged 11, Caiden Wakerley was just five years old ...

Ortega-Hernandez, O. and Shoenfeld, Y. (2012) Mixed Connective Tissue Disease An Overview of Clinical Manifestations, Diagnosis and Treatment. Best Practice & Research Clinical Rheumatology, 26, 61-72 ...

Background Mixed connective tissue disease (MCTD) is an immune-mediated, systemic disorder of unknown cause. Objective To assess the prevalence, pattern and severity of interstitial lung disease (ILD) ...

Background: Mixed connective tissue disease (MCTD) with a range of clinical manifestations and is recognized as an independent disease with similarities to systemic lupus erythematosus (SLE) and ...

The MosaiQ AiPlex CTDplus assay enables a syndromic approach and accurate serological evaluation of Rheumatoid Arthritis (RA) and systematic connective tissue diseases (CTD) for healthcare providers.

Systemic autoimmune Rheumatic Diseases such as Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus, Systemic Sclerosis (also known as Scleroderma), Sjögren's syndrome, idiopathic inflammatory ...

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.